Yayınlar & Eserler

Yayın Ağı
Makaleler 19
Tümü (19)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (14)
ESCI (3)
Scopus (14)
TRDizin (5)
Diğer Yayınlar (1)

1. Comparison of in vitro lipolysis, sequential lipolysis – ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulations

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
European Journal of Pharmaceutical Sciences , cilt.216, ss.1-19, 2026 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Özel Tıbbi Amaçlı Gıdaların Değerlendirilmesi

Yılmaz Usta D.
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.49, sa.2, ss.562-578, 2025 (Scopus) Sürdürülebilir Kalkınma

3. Performance of oral Bosentan-loaded SNEDDS and S-SNEDDS tablets: Biodistribution in mice, echocardiography and histology studies in pulmonary arterial hypertension rat model

Yılmaz Usta D., Olğaç S., Demirel M. A., Kula S., Elmas Ç., Sezginer P., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.212, sa.7, ss.1-18, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Lipit Temelli Taşıyıcı Sistemler-II: Katı Kendiliğinden Emülsifiye İlaç Taşıyıcı Sistem Formülasyonlarına Bakış: Geleneksel Derleme

Yılmaz Usta D., Teksin Z. Ş.
Literatür Eczacılık Bilimleri Dergisi , cilt.14, sa.1, ss.17-25, 2025 (Hakemli Dergi) Sürdürülebilir Kalkınma

5. Pre-formulation Studies of Lipid-based Formulation Approach for A Poorly Water-soluble BCS Class II Model Drug: Bosentan

Yılmaz Usta D., Teksin Z. Ş.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.22, sa.2, ss.140-153, 2025 (ESCI) Sürdürülebilir Kalkınma

6. Optimization and validation of HPLC methods for in vitro and ex vivo analyses of bosentan monohydrate in FDA-recommended and biorelevant media

Yılmaz Usta D., Olğaç S., Teksin Z. Ş.
Istanbul Journal of Pharmacy , cilt.54, sa.3, ss.466-475, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

7. Lipit Temelli Taşıyıcı Sistemler-I: Kendiliğinden Emülsifiye İlaç Taşıyıcı Sistem Formülasyonlarına Bakış: Geleneksel Derleme

Yılmaz Usta D., Teksin Z. Ş.
Literatür Eczacılık Bilimleri Dergisi , cilt.13, sa.3, ss.165-176, 2024 (Hakemli Dergi) Sürdürülebilir Kalkınma

8. Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation

YILMAZ USTA D., TEKSİN Z. Ş., TUĞCU DEMİRÖZ F. N.
AAPS PHARMSCITECH , cilt.25, sa.5, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

9. Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye

ÇOBAN Ö., YILMAZ USTA D., Pinar S. G.
Dissolution Technologies , cilt.31, sa.1, ss.40-49, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

10. Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging

Yılmaz Usta D., Olgac S., Tımur B., Teksin Z. Ş.
International Journal of Pharmaceutics , cilt.643, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model

Timur B., Yılmaz Usta D., Teksin Z. S.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.77, 2022 (SCI-Expanded) identifier identifier

12. Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media

Yılmaz Usta D., İnceçayır T.
AAPS PHARMSCITECH , cilt.23, sa.6, 2022 (SCI-Expanded) identifier identifier identifier

13. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment

Usta D., Timur B., TEKSİN Z. Ş.
European Journal of Pharmaceutical Sciences , cilt.174, 2022 (SCI-Expanded) identifier identifier identifier

14. Comparison of tablet splitting techniques for dosing accuracy of nebivolol tablets: Hand splitting versus tablet cutter and knife

Olgac S., Usta D. Y., İNCEÇAYIR T.
SAUDI PHARMACEUTICAL JOURNAL , cilt.29, sa.12, ss.1486-1491, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

15. Role of Surfactants on Dissolution Behavior of Tamoxifen

İNCEÇAYIR T., Olgac S., Usta D. Y., TEKSİN Z. Ş.
DISSOLUTION TECHNOLOGIES , cilt.28, sa.2, 2021 (SCI-Expanded, Scopus) identifier identifier

16. Biopharmaceutics, Pharmacokinetics and Patent Evaluations of Drugs Used in the Treatment of COVID-19: Current Status in the Development of Generic Drugs in Turkey

YILMAZ USTA D., TEKSİN Z. Ş.
GAZI MEDICAL JOURNAL , cilt.31, ss.498-509, 2020 (ESCI) Sürdürülebilir Kalkınma identifier identifier

17. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system

Gulbag S., YILMAZ USTA D., Gultekin H. E., Oktay A. N., Demirtas O., Karakucuk A., et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.5, ss.512-519, 2018 (SCI-Expanded) identifier identifier identifier

18. Evaluation of in vitro Dissolution Characteristics of Flurbiprofen, a BCS Class IIa Drug

YILMAZ USTA D., demirtaş ö., ökçelik c., uslu a., TEKSİN Z. Ş.
FABAD J. Pharm. Sci , cilt.43, sa.2, ss.27-34, 2018 (Hakemli Dergi)

19. İn Vitro Çözünme Hızı Çalışmalarında Yeni Yaklaşımlar

YILMAZ USTA D., TEKSİN Z. Ş.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.40, sa.1, ss.33-40, 2017 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 40

1. Evaluation of Artificial Intelligence Data for Formulation Development Studies

Yılmaz Usta D.
19th Nanoscience and Nanotechnology Conference, Ankara, Türkiye, 27 - 29 Ağustos 2025, ss.362, (Özet Bildiri)

2. Preparation of Finasteride Loaded Self-nanoemulsifying Drug Delivery Systems Using Box Behnken Design

Bebek G., Negiz H., Turan Ayhan E., Yılmaz Usta D., İlbasmış Tamer S.
JOINT EUFEPS - ÖPhG Meeting 2025, Vienna, Avusturya, 19 - 21 Şubat 2025, (Özet Bildiri)

3. In vitro performance of Exemestan-loaded SNEDDS formulations: Dissolution in biorelevant media and antiproliferative activity on MCF-7 cell line

TİMUR B., VARAN G., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Avusturya, 19 - 21 Şubat 2025, (Özet Bildiri)

4. Evaluation of EXE-loaded SNEDDS using simultaneous lipolysis/ex-vivo permeability and lipolysis/in situ single-pass intestinal perfusion method

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Development and Characterization of Finasteride-loaded SNEDDS Formulations for Alopecia Treatment

Bebek G., Negiz H., Turan E., Yılmaz Usta D., İlbasmış Tamer S.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Histology and pharmacodynamic echocardiography studies of bosentan-loaded SNEDDS and S-SNEDDS: New oral drug delivery systems for pulmonary arterial hypertension

Yılmaz Usta D., Olğaç S., Demirel M. A., Kula S., Kavgacı A., Sezginer P., et al.
EUFEPS Annual Meeting 2023, Lizbon, Portekiz, 31 Mayıs - 02 Haziran 2023, ss.165, (Özet Bildiri)

7. Evaluation of pharmacokinetic and pharmacodynamic real-time biodistribution of bosentan formulations

Yılmaz Usta D., Teksin Z. Ş.
FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Hollanda, 1 - 03 Haziran 2022, ss.47, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Assessment of in vitro digestion for exemestane-loaded lipid-based formulations

Timur B., Yılmaz Usta D., Teksin Z. Ş.
FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Hollanda, 1 - 03 Haziran 2022, ss.45-46, (Özet Bildiri) Sürdürülebilir Kalkınma

9. SOLID-STATE CHARACTERIZATION STUDIES OF BOSENTAN-LOADED SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS) COMPRISING OF NEUSILIN® US2

Yılmaz Usta D., Olgac S., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.36, (Özet Bildiri)

10. IN VITRO CHARACTERIZATION OF EXEMESTANE-LOADED SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM CONTAINING MEDIUM CHAIN MONO AND DIGLYCERIDES

Timur B., Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.37, (Özet Bildiri)

11. DEVELOPMENT AND VALIDATED OF UV SPECTROPHOTOMETRIC AND HPLC METHOD OF BOSENTAN MONOHYDRATE FOR IN VITRO AND EX-VIVO SAMPLES

Yılmaz Usta D., Olgac S., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.33, (Özet Bildiri)

12. DEVELOPMENT OF IN VITRO LIPOLYSIS-PERMEATION METHOD TO ESTIMATE ORAL ABSORPTION OF EXEMESTANE-LOADED LIPID-BASED FORMULATION

Timur B., Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.30, (Özet Bildiri)

13. MODELING AND COMPARISON OF IN VITRO DISSOLUTION PROFILES OF BOSENTAN MONOHYDRATE: COMMERCIAL TABLET VS S-SNEDDS TABLET

Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.35, (Özet Bildiri)

14. Comparison of Tablet Splitting Techniques for Dosing Accuracy of Nebivolol Tablets: Hand Splitting Versus Tablet Cutter And Knife

Olgac S., Yılmaz Usta D., İnceçayır T.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.32, (Özet Bildiri)

15. Evaluation of Bosentan-Loaded Self-nanoemulsifying Drug Delivery Systems Containing Peceol

YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 Temmuz 2021, (Özet Bildiri)

16. Assessment The Correlation Between In Vitro Dissolution and In Vitro Intestinal Lipolysis Data for Bosentan Loaded Lipid-Based Formulations

TİMUR B., YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 Temmuz 2021, (Özet Bildiri)

17. Evaluation of Ex-vivo Permeability and In Vitro Dissolution of BOS-loaded S-SNEDDS Tablets

YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 Temmuz 2021, (Özet Bildiri)

18. Validated HPLC Method for the Determination of Tenofovir and its Application for In-Vitro and Ex-Vivo Investigations of Tenofovir Loaded Double Nanoemulsion

Olğaç S., Yılmaz Usta D., Erman N. A., İnceçayır T., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

19. Modeling and comparison of in vitro dissolution profiles of naproxen sodium tablets in biorelevant media

OLĞAÇ S., YILMAZ USTA D., DEMİRDAŞ B., ERMAN N. A., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

20. Comparison of biorelevant dissolution of medium chain mono and diglycerides based bosentan-loaded self-nanoemulsifying formulations

YILMAZ USTA D., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

21. DEVELOPMENT AND OPTIMIZATION OF SELFNANOEMULSIFYING DRUG DELIVERY SYSTEM OF BOSENTAN USING BOX BEHNKEN DESIGN

Yılmaz Usta D., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

22. Evaluation of in vitro-in vivo relationship: Bosentan-loaded lipid based formulation versus commercial product

TİMUR B., YILMAZ USTA D., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

23. Enhancement of in vitro dissolution, in vitro lipolysis, ex-vivo permeability, and fasted and fed state bioavailability of Bosentan-solid SNEDDS: New oral drug delivery system for pulmonary arterial hypertension

Yılmaz Usta D., Olğaç S., Timur B., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, İsveç, 7 - 09 Haziran 2021, ss.91-92, (Özet Bildiri)

24. In vitro, ex-vivo, and in vivo evaluation of Bosentan-loaded self nanoemulsifying drug delivery system

Yılmaz Usta D., Timur B., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, İsveç, 7 - 09 Haziran 2021, ss.90-91, (Özet Bildiri)

25. The Development of Exemestane-loaded Self-nanoemulsifying Drug Delivery System

Timur B., Yılmaz Usta D., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, İsveç, 7 - 09 Haziran 2021, ss.65, (Özet Bildiri)

26. Evaluation of In-vitro Dissolution Ex-vivo Permeability of Tenofovir Double Nanoemulsion Produced with the High Energy Method for Oral Drug Administration

Olğaç S., Yılmaz Usta D., İnceçayır T., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, İsveç, 7 - 09 Haziran 2021, ss.65-66, (Özet Bildiri)

27. Development and In Vitro Characterization of Bosentan-Loaded Self-Nanoemulsifying Drug Delivery System

Yılmaz Usta D., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Avusturya, 11 Mayıs 2021, (Tam Metin Bildiri)

28. Investigation of Nanostructured Lipid Carriers (NLC)-Based Gel for the Transdermal Delivery of Ibuprofen: Preparation, Characterization, Textural Properties, and Ex Vivo Skin Permeation Studies

Yılmaz Usta D., Tuğcu Demiröz F. N., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Avusturya, 11 Mayıs 2021, (Tam Metin Bildiri)

29. Comparison of In Vitro Lipolysis of Bosentan-Loaded Lipid-Based Formulations in Fasted State Biorelevant Media

Timur B., Yılmaz Usta D., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Avusturya, 11 Mayıs 2021, (Tam Metin Bildiri)

30. Evaluation of Fasted and Fed State Intestinal In Vitro Lipolysis Test for Bosentan Loaded Lipid-Based Drug Delivery Systems

TİMUR B., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

31. Development and Characterization of Bosentan Loaded Solid Self Nanoemulsifying Drug Delivery System (S-SNEDDS)

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
8th BBBB Conference on Pharmaceutical Sciences, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

32. Development and Characterization of Bosentan Loaded Solid Self Nanoemulsifying Drug Delivery System (S-SNEDDS)., Çeşme-İzmir, Türkiye

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

33. Role of Surfactants and pH on Dissolution Behavior of Tamoxifen, a Weakly Basic BCS Class II Drug

OLGAÇ S., YILMAZ USTA D., İNCEÇAYIR T., TEKSİN Z. Ş.
AAPS PharmSci 360 Annual Meeting, Walter E. Washington Convention Center, Washington DC, USA, November 4-7, 2018, Washington, Kiribati, 4 - 08 Kasım 2018, (Özet Bildiri)

34. Modeling and Comparison of In-Vitro Dissolution Profiles of Tamoxifen Citrate Immediate Release Tablets

YILMAZ USTA D., OLGAÇ S., İNCEÇAYIR T., TEKSİN Z. Ş.
19th International Pharmaceutical Technology Symposium (IPTS 2018), Antalya, Turkey, p: 168-169, September 17-19, 2018, Antalya, Türkiye, 17 - 19 Eylül 2018, ss.168-169, (Tam Metin Bildiri)

35. MECHANICAL PROPERTIES AND EX-VIVO SKIN PERMEATION EVALUATIONS OF IBUPROFEN EMULSION GEL FOR TOPICAL DELIVERY

YILMAZ USTA D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
ISOPS 2018, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

36. THE DEVELOPMENT OF SNEDDS CONTAINING BOSENTAN USING LONG CHAIN MONO AND DIGLYCERIDE MIXTURES

YILMAZ USTA D., TEKSİN Z. Ş.
European Federation for Pharmaceutical Sciences (EUFEPS) Annual Meeting 2018, Atina, Yunanistan, 24 - 26 Mayıs 2018, (Özet Bildiri)

37. Construction of Pseudo-Ternary Phase Diagrams for the Preformulation SNEDDS Development of Bosentan, a BCS Class IIa

Yılmaz Usta D., Teksin Z. Ş.
11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, İspanya, 19 - 22 Mart 2018, (Tam Metin Bildiri)

38. Evaluation of Water and Oil Solubilities of Bosentan, a BCS Class IIa Drug

YILMAZ USTA D., TEKSİN Z. Ş.
2nd International Gazi Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

39. New Perspective For Memantine Orally Disintegrating Tablet SeDeM Expert System

OKTAY A. N., GÜLBAĞ S., DEMİRTAŞ Ö., YILMAZ USTA D., GÜLTEKİN H. E., KARAKÜÇÜK A. E., et al.
GPSS International Gazi Pharma Symposium Series, 12 - 15 Kasım 2015, (Özet Bildiri)

40. EVALUATION OF IN VITRO DISSOLUTION CHARACTERISTICS OF NON STEROIDAL ANTIINFLAMMATORY DRUGS IN THE TURKISH DRUG MARKET 1 FLURBIPROFEN A BCS CLASS IIa DRUG

YILMAZ USTA D., demirtaş ö., uslu a., cumhur ö., TEKSİN Z. Ş.
International Gazi Pharma Symposium Series, Antalya, Türkiye, 12 - 15 Kasım 2015, ss.103, (Özet Bildiri)
Kitaplar 2

1. Farmasötik Teknoloji Laboratuvar Kitabı

Acartürk F., İlbasmış Tamer S., İnceçayır T., Mutlu Ağardan N. B., Takka S., Teksin Z. Ş., et al.
Gazi Üniversitesi Yayınları, Ankara, 2023 Sürdürülebilir Kalkınma

2. Liposomes in photodynamic therapy

Çoban Ö., Yılmaz Usta D., Gülbağ Pınar S.
Nanomaterials for Photodynamic Therapy, Prashant Kesharwani, Editör, Woodhead Publishing - Elsevier, Cambridge, ss.141-176, 2023 Sürdürülebilir Kalkınma
Metrikler

Yayın

61

Yayın (WoS)

14

Yayın (Scopus)

14

Atıf (WoS)

123

H-İndeks (WoS)

7

Atıf (Scopus)

161

H-İndeks (Scopus)

8

Atıf (Scholar)

191

H-İndeks (Scholar)

8

Proje

9

Fikri Mülkiyet

6
BM Sürdürülebilir Kalkınma Amaçları